William John Scheessele's Insider Trades & SAST Disclosures
William John Scheessele's most recent trade in Humacyte Inc was a trade of 283,101 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William John Scheessele.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 283,101 | 283,101 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 276,000 | 276,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.09 per share. | 13 Dec 2022 | 5,000 | 15,525 | - | 3.1 | 15,450 | Common Stock |
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 136,000 | 136,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 24 May 2022 | 10,525 | 10,525 | - | 4.7 | 49,678 | Common Stock |
| Humacyte Inc | William John Scheessele | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 157,558 | 157,558 | - | - | Stock Options (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges